Ainos to Commence Clinical Trial of Veldona-Based Drugs for Treating Pet Disease

Share this

Ainos to Commence Clinical Trial of Veldona-Based Drugs for Treating Pet Disease


  • Ainos reported the commencement of clinical evaluation for novel Veldona-based drugs to treat feline chronic gingivostomatitis (FCGS). The trials will run for ~10mos., from May 24, 2024 to Mar 31, 2025
  • The study aims at improving health evaluations by both pet owners & veterinarians post-treatment among cats (n=30), divided into low (6000 IU/time) & high dose (12000 IU/time) treatment arms, & assessing the ability of steroids or other immunosuppressive drugs' reduced dosage & frequency   
  • The prior studies have confirmed partial immune system regulation with interferon’s oral mucosal administration in experimental animals, depicted its proper distribution in head & neck lymph nodes as well as mesenteric lymphatic systems plus minimizing immunogenicity & bone marrow suppression

Ref: Ainos | Image: Ainos

Related News:- Siemens Healthineers Receives the US FDA Approval for Biograph Vision.X PET/CT Scanner

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Click here to­ read the full press release 

Disha Nankani

Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions